| Literature DB >> 29023758 |
Julio Cesar López-Romero1, Jesús Fernando Ayala-Zavala1, Gustavo Adolfo González-Aguilar1, Etna Aida Peña-Ramos1, Humberto González-Ríos1.
Abstract
Agave leaves are considered a by-product of alcoholic beverage production (tequila, mezcal and bacanora) because they are discarded during the production process, despite accounting for approximately 50% of the total plant weight. These by-products constitute a potential source of Agave extracts rich in bioactive compounds, such as saponins, phenolic compounds and terpenes, and possess different biological effects, as demonstrated by in vitro and in vivo tests (e.g. antimicrobial, antifungal, antioxidant, anti-inflammatory, antihypertensive, immunomodulatory, antiparasitic and anticancer activity). Despite their positive results in biological assays, Agave extracts have not been widely evaluated in food systems and pharmaceutical areas, and these fields represent a potential route to improve the usage of Agave plants as food additives and agents for treating medical diseases.Entities:
Keywords: Agave by-products; bioactive compounds; biological activities; foods; pharmaceutical
Mesh:
Substances:
Year: 2017 PMID: 29023758 DOI: 10.1002/jsfa.8738
Source DB: PubMed Journal: J Sci Food Agric ISSN: 0022-5142 Impact factor: 3.638